palbociclib,letrozole,lee011
novartis,pfizer
['paloma-2', 'monaleesa-2']
paloma-2 does not demonstrate an improvement in os for 1st line palbocilib plus letrozole. missing data may have impacted result. post hoc sensitivity to correct for this missing data didn t alter results much. big why paloma-2 vs monaleesa-2 for os #asco2022 
Professor of Translational Oncology and Consultant Medical Oncologist